| Literature DB >> 34181409 |
David Sedlák1, Tyler A Wilson2, Werner Tjarks3, Hanna S Radomska4, Hongyan Wang4, Jayaprakash Narayana Kolla1, Zbigniew J Leśnikowski5, Alena Špičáková6, Tehane Ali3, Keisuke Ishita3, Liva Harinantenaina Rakotondraibe3, Sandip Vibhute2, Dasheng Wang2, Pavel Anzenbacher6, Chad Bennett2,7, Petr Bartunek1, Christopher C Coss4,7.
Abstract
Selective agonism of the estrogen receptor (ER) subtypes, ERα and ERβ, has historically been difficult to achieve due to the high degree of ligand-binding domain structural similarity. Multiple efforts have focused on the use of classical organic scaffolds to model 17β-estradiol geometry in the design of ERβ selective agonists, with several proceeding to various stages of clinical development. Carborane scaffolds offer many unique advantages including the potential for novel ligand/receptor interactions but remain relatively unexplored. We synthesized a series of para-carborane estrogen receptor agonists revealing an ERβ selective structure-activity relationship. We report ERβ agonists with low nanomolar potency, greater than 200-fold selectivity for ERβ over ERα, limited off-target activity against other nuclear receptors, and only sparse CYP450 inhibition at very high micromolar concentrations. The pharmacological properties of our para-carborane ERβ selective agonists measure favorably against clinically developed ERβ agonists and support further evaluation of carborane-based selective estrogen receptor modulators.Entities:
Year: 2021 PMID: 34181409 DOI: 10.1021/acs.jmedchem.1c00555
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446